IMC Chicago
MDGL icon

IMC Chicago’s Madrigal Pharmaceuticals MDGL Stock Holding History

IMC Chicago’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Buy
10,847
+3,052
+39% +$1.56M ﹤0.01% 1976
2026
Q1 		$4.08M Sell
7,795
-4,256
-35% -$2.03M ﹤0.01% 1964
2025
Q4 		$7.02M Buy
+12,051
New +$6.16M ﹤0.01% 1482

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IMC Chicago's MDGL Position: Q2 2026 in Review

IMC Chicago increased its Madrigal Pharmaceuticals (MDGL) stake by 39% in Q2 2026, buying an estimated $1.56M and bringing the position to 10,847 shares worth $5.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

IMC Chicago first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.02M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • IMC Chicago held 10,847 shares of Madrigal Pharmaceuticals worth $5.82M as of Q2 2026.
  • IMC Chicago bought 3,052 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.56M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1976 holding.
  • IMC Chicago first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • IMC Chicago's Madrigal Pharmaceuticals position peaked at $7.02M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.